KeyBanc cuts Salesforce stock price target on software multiples By Investing.com

KeyBanc cut its Salesforce price target to $290 from $300 but kept an Overweight rating, citing continued software multiple pressure. Salesforce reported in-line organic metrics, reiterated constant-currency guidance, and said Agentforce net-new ARR grew $400 million sequentially with 205% year-on-year growth; it also posted Q1 fiscal 2027 EPS of $3.88 versus $3.13 expected and revenue of $11.13 billion versus $11.05 billion expected. Overall analyst sentiment remains constructive despite the modest target cut.

Analysis

CRM is being treated like a multiple story again, but the more important signal is that operating cadence is no longer deteriorating despite a tough sell-side setup. The market had already discounted a sluggish start and further software de-rating, so modestly better AI consumption trends create a cleaner setup for multiple stabilization than for near-term fundamental upside. That matters because software re-rates rarely begin with headline growth acceleration; they usually start when investors stop cutting estimates and start paying for durability again.

The second-order winner is the broader enterprise AI stack: if Agentforce usage keeps inflecting, CRM becomes a reference case for monetized AI inside a legacy SaaS base, which should support multiples across the group. That likely helps names with visible AI attach rates and penalizes vendors whose AI narratives remain unproven. Conversely, if the usage data doesn’t convert into faster net retention or material ACV expansion by late summer, the current enthusiasm becomes fragile and the stock can revert back to being judged on the slower core cloud maturity cycle.

The key risk is timing mismatch: AI usage can spike before revenue does, and investors may overpay for what is still a consumption trend rather than a durable earnings re-acceleration. In the near term, the stock can grind higher simply because the bar was low; over a 3-6 month horizon, the real test is whether second-half acceleration shows up in bookings and guidance math rather than anecdotes. A failure there would likely compress the same multiple the upgrade is trying to defend.

Contrarian view: this is less about undervaluation and more about sentiment repair. The stock may look cheap versus targets, but the market is demanding proof that AI is additive to the base business rather than just a narrative overlay; until that bridge is visible, upside is more likely to come from multiple mean reversion than from estimate revisions.

Key Decisions for Investors

• Long CRM on a 1-3 month horizon into the next catalyst cycle; use a staged entry on weakness, targeting a 15-20% move if software multiples stabilize and AI usage continues to inflect. Risk: multiple compression resumes if broader software de-rates.
• Buy CRM call spreads expiring after the next quarterly print to express upside from sentiment repair with defined downside; best risk/reward if implied vol is still cheap versus the stock’s potential gap-up on guidance credibility.
• Pair trade: long CRM / short a lower-quality enterprise software name with weaker AI monetization visibility over the next 2-4 months. The thesis is that the market will reward measurable AI attach and punish pure narrative exposure.
• If CRM rallies sharply before evidence of booking acceleration, trim into strength rather than chase; the trade is vulnerable to a 'usage without monetization' reversal over a 6-12 week window.